New prostate surgery technique aims to save erections and bladder control

NCT ID NCT03317990

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This trial tests a new surgical method called NeuroSAFE, which uses real-time tissue analysis during robotic prostate removal to help surgeons avoid damaging nerves. The study includes 407 men with prostate cancer who are potent and continent before surgery. The goal is to see if this technique improves erectile function and urinary continence after surgery compared to standard robotic prostate removal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • NHS Greater Glasgow & Clyde

    Glasgow, United Kingdom

  • North Bristol NHS Trust

    Bristol, BS10 5NB, United Kingdom

  • Nottingham University Hospitals

    Nottingham, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, S10 2JF, United Kingdom

  • University College London Hospital

    London, NW1 2BU, United Kingdom

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

NeuroSAFE procedure (a surgical technique using real-time tissue analysis during prostate removal)

What this could lead to

If successful, this technique could help men undergoing prostate cancer surgery retain better erectile function and urinary control, improving quality of life.

What could go wrong

This is a surgical technique study, not a new drug. The benefit may be small or not apply to all men. The trial is not yet complete, and results are pending.

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.